ClinicalTrials.gg
RecruitingNCT03838536Updated Apr 20, 2026

Synergistic Activity of Human Milk Nutrients and Infant Cognition

An interventional study of Whole Egg Powder and Egg White Powder in Breastfeeding, Exclusive, sponsored by University of North Carolina, Chapel Hill. Recruiting at 1 site in United States. Open to participants aged 3 Months to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Feb 2019; still recruiting 7 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
3 Months to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 251 studies in Breast Feeding with a site in United States — 43 open to participants now, 49 under way, none of them phase 3. Breast Feeding · United States.

Planned enrollment
100th of 202
84 · median 83
Started
2019
with 16 others
No phase
164 of 251
26 open now
Primary completion
2027-03
later than 16 of 48 live
Registered
128th of 251
by date

Among the 251 studies in Breast Feeding with a site in United States, this one is the 100th largest by planned enrollment of the 202 interventional ones that give a count, is one of 17 that started in 2019, is one of 164 with no phase, reaches primary completion later than 16 of the 48 other live ones, and was the 128th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

43 of the 251 studies in Breast Feeding with a site in United States are open now. Recruiting first, the newest first:

38 more — sign in →

All 43 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 3 Months to 35 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 251 studies in Breast Feeding with a site in United States, or all of them as a file.
02

Study summary

Purpose: To establish a whole food, egg, as a viable study material to supplement mothers and infants with nutrients that support optimal brain development. There will be 84 breastfeeding dyads, 3 months postnatal.

Mothers will be randomized to a whole egg or egg white (due to lack of an appropriate control food). Initial diet intake will be screened using the NDSR. Participants will come to the lab 3 times across 3 months (age 3 months, 4.5 months, and 6 months). Milk, saliva, and plasma will be collected from the mother, while saliva and plasma (heel stick) are collected from the infant. Diet data will be collected at each visit. The infant will complete a recognition memory test using electrophysiology at 6 months as well as the Bayley Scales of Infant Development at 4.5 months. The mother will complete a temperament questionnaire at 3 months and 6 months.

03

Conditions studied

  • Breastfeeding, Exclusive

Browse trials for

Keywords

  • Breastfeeding
  • Eggs
  • Baby
04

Who can participate

Ages eligible
3 Months to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • infant is 12-15 weeks of age at enrollment
  • healthy, lactating mother age 18-35
  • gave birth at >38 weeks gestation without remarkable incident
  • consuming \<=50% of the recommended amounts of 2 of the 3, DHA, choline, and lutein

Exclusion criteria

Exclusion Criteria:

  • infant with diagnosis or documented suspicion of developmental delay
  • egg allergy or family history of egg allergy
  • gestational diabetes
  • any documented seizure activity
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Whole egg powder

    Participants are given whole egg powder which contains high levels of the nutrients choline, lutein, and docosahexaenoic acid.

    Dietary Supplement: Whole Egg Powder

  • Placebo comparator
    Egg white powder

    The participants are given an egg white powder that does not contain the target nutrients (choline, lutein, and docosahexaenoic acid).

    Dietary Supplement: Egg White Powder

Interventions

  • Dietary supplementWhole Egg Powder

    Breastfeeding mothers will consume the equivalent of 5 whole eggs per week for 3 months.

  • Dietary supplementEgg White Powder

    Breastfeeding mothers will consume the equivalent of 5 egg whites per week for 3 months.

06

What researchers measure

Primary outcomes

  1. Recognition Memory in an Oddball Task

    The difference in microvolts between the negative deflection to novel pictures and the negative deflection to familiar pictures at approximately 100-400ms after the pictures come on the screen will be measured in an event-related potentials (ERP) paradigm. The investigators hypothesize that the whole egg group will have better memory for the familiar pictures than the egg white group.

    Time frame: 13 weeks (at 6 months of age)

Other outcomes

  1. Bayley Scales of Infant Development (BSID)

    BSID administered at 4.5 months

    Time frame: 6 weeks (at 4.5 months of age)

07

Study locations

1 of 1 sites recruiting
  • Nutrition Research Institute
    Kannapolis, North Carolina 28081, United States
    Recruiting
    • Carol L Cheatham, Ph.D. · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2019 (actual). Primary completion is estimated for Mar 2027, 97 months after the start.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 97 months is above that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2019
First posted
Feb 12, 2019
StartActual
Feb 5, 2019
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Apr 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03838536
Collaborators
Egg Nutrition Center
Responsible party
Sponsor
First posted
Feb 12, 2019
Start date
Feb 5, 2019
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Apr 20, 2026

Study contacts

Carol L Cheatham, PhD
Contact
carol_cheatham@unc.edu
704-250-5010
Study Coordinator
Contact
feedingbrains@unc.edu
704-250-5018
Carol L Cheatham, Ph.D.
principal investigator · Associate Professor, University of North Carolina-Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion